iiinova — where your digital self keeps evolving

Dr. Don S Dizon @drdonsdizon.bsky.social · 07/04/2026

Excited for the 3rd Collaboration for Outcomes using Social Media in Oncology meeting. All are welcome, MD not required. LOL. The goal is to learn from each other. No more silos.

000

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

For people with metastatic PDL1+ TRIPLE NEG BREAST CANCER, Sacituzumab+pembrolizumab (P) significantly increases PFI by ~3m vs chemo+P (a 35% improvement). Whether its meaningful depends on the person offered it and whether it will ultimately improve OS. #ASCENT meetings.asco.org/abstracts-pr... 8/8

meetings.asco.org

Program Guide – ASCO Meeting Program Guide

030

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

For people with advanced hormone receptor positive PIK3CA mutated BREAST CANCER, 1st line tx w/ inavolisib|palbociclib|fulvestrant (PF) increased OS over placebo + PF by 7 months- an almost 30% improvement. 30-month overall survival was also improved by 10%. meetings.asco.org/abstracts-pr... 7/8

meetings.asco.org

Program Guide – ASCO Meeting Program Guide

150

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

For people with metastatic triple-positive BREAST CANCER (Hormone and HER2 positive), one trial of 77p reported that ribociclib, trastuzumab, and letrozole resulted in a 61% overall response rate and median progression-free interval of 30 months. 6a/8

asco.org

Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. - ASCO

151

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

Whether monitoring blood for ctDNA over time improves overall survival through earlier intervention has to be proven. But the best med will always be the one someone is willing to stay on. #SERENA6 meetings.asco.org/abstracts-pr... 5b/8

meetings.asco.org

Program Guide – ASCO Meeting Program Guide

100

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

In the absence of frank disease progression, for people with hormone-positive BREAST CANCER, the only reason to switch treatment from an aromatase inhibitor (AI) to a selective estrogen receptor degrader (SERD) is if toxicity is making it hard to take the AI. 5a/8

meetings.asco.org

Program Guide – ASCO Meeting Program Guide

130

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

Interestingly, the OS benefit was bigger than the Progression Free Interval which was improved by only one month. It also added no additional toxicity to treatment. 4b/8 #ROSELLA ascopubs.org/doi/10.1200/...

ascopubs.org

ASCO Publications

110

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

For people with platinum-resistant recurrent OVARIAN CANCER, a novel drug that targets the glucocorticoid receptor, called Relacorilant, in combination with nAb-paclitaxel improved overall survival (OS) by 5 months over nAb-paclitaxel alone. 4a/8 #ROSELLA

120

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

For people with OVARIAN CANCER, surgery should be done if their gyn onc feels they can have all tumor resected rather than undergoing medical therapy (neo adjuvant chemo) first. That’s been the standard everywhere I’ve worked and the #TRUST trial affirms this. meetings.asco.org/abstracts-pr... 3/8

meetings.asco.org

Program Guide – ASCO Meeting Program Guide

120

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

PFS (Progression Free Survival) needs to be renamed. People don’t experience “progression”. A cancer may progress at some interval, and that’s what it should be called: PFI. The only survival is whether one is alive or dead- OS (Overall Survival). We need to stop conflating them. 2/8

160

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/06/2025

As I make my way home from #Chicago (finally!) here's what I come away with from #ASCO25 I had hoped to live blog from the meeting but time got the better of me! Here goes.... 1/8

1124

Dr. Don S Dizon @drdonsdizon.bsky.social · 31/05/2025

Have fun at your #asco25 session. I will be watching remotely and rooting for you all the same.

010

Dr. Don S Dizon @drdonsdizon.bsky.social · 30/05/2025

I shared the ASCO stage with Dr Dawn Hershman when we were both awarded a career development award as we were starting our careers. Amazing to share the stage with her again as we are awarded once more at #ASCO25. Truly honored and excited to do so.

2243

Dr. Don S Dizon @drdonsdizon.bsky.social · 18/05/2025

I'm proud to be a part of this international community seeking to improve both access and outcomes for people with breast cancer worldwide.

010

Dr. Don S Dizon @drdonsdizon.bsky.social · 18/05/2025

a great 4d in #Munich with @myesmo.bsky.social. Spoke on the importance of sex after cancer & chaired a session on Breast Cancer in Young Women. With @tanjaspanic.bsky.social from #Slovenia my pal Matteo Lambertini from #Italy, Prof Inez Vaz-Luis from #France, and Antigoni Kretsi from #Greece

2102

Reposted by Dr. Don S Dizon

Megan Ranney MD MPH @meganranney.bsky.social · 16/05/2025

… and Molly is not alone. More than $2.6B of ongoing research has been canceled (with much more this week, at Harvard). With each cancellation: We are losing so much knowledge. Losing the next generation of scientists. Losing our ability to protect our health, both now & for the future. 🧪🩺😷

221779

Reposted by Dr. Don S Dizon

Binaytara @binaytara.bsky.social · 26/04/2025

The community engagement session led by @drdonsdizon.bsky.social at #SCHD25 demonstrated impactful outcomes. The work of Dr. Memnun Seven with cancer survivors, Dr. Andrew Sussman's CAB strategies, and Dr. Vida Henderson's media approaches show that authentic partnerships improve results.

051

Dr. Don S Dizon @drdonsdizon.bsky.social · 21/04/2025

I'm not practicing much but I am who I am because of my very Catholic parents who taught me right from wrong and to care for everybody. I admired Pope Francis. He will be missed in this very turbulent world.

171

Dr. Don S Dizon @drdonsdizon.bsky.social · 10/04/2025

Sexuality is so innately human we need to be able to talk about it for people with cancer. Join me, Linda Bosserman, and @drannekatz.bsky.social to do just that. And thanks to @cancercaremascc.bsky.social for offering this!

051

Dr. Don S Dizon @drdonsdizon.bsky.social · 31/03/2025

Like I said, change is a good thing. Sad to leave Brown University Health but super excited to join such a venerable institution as @tuftsmedschool.bsky.social

11232

Dr. Don S Dizon @drdonsdizon.bsky.social · 22/03/2025

Change is always a good thing. Well, maybe not always. But when opportunities arise, they deserve to be explored. Comfortable isn't synonymous with satisfied.

030

Dr. Don S Dizon @drdonsdizon.bsky.social · 17/03/2025

Come learn about cancer and its impact on sexuality. All are invited- you do not need to be an oncologist to discuss but all people with cancer deserve the chance to rediscover their sexual selves. Registration is OPEN for @cancercaremascc.bsky.social in #Seattle. mascc.org/annualmeetin...

mascc.org

Sexual Health Course - MASCC/ISOO Annual Meeting 2025

Fundamentals of Sexual Health After Cancer: An Interactive Course Co-Chairs: Linda Bosserman and Anne Katz Additional Faculty: Don Dizon Duration: Wed Jun 25 – Thurs Jun 26Registration fee: $200 USDMa...

051

Dr. Don S Dizon @drdonsdizon.bsky.social · 14/03/2025

Fwiw. You don't need to be an MD to take this course or to help people with questions on their Sexual Health after cancer. You have to want to learn and willing to ask.

041

Dr. Don S Dizon @drdonsdizon.bsky.social · 14/03/2025

Here it is. A definitive course on sexual health after a cancer diagnosis! See you there, D #medsky #oncsky

040

Dr. Don S Dizon @drdonsdizon.bsky.social · 12/03/2025

We are a connected society more than ever before. Please, for the love of all things sacred, vaccinate your kids.

031

Dr. Don S Dizon @drdonsdizon.bsky.social · 12/03/2025

Thankful @bsky.app let's me follow people and form my communities, and also thankful it gives me access to news, not news from an echochamber, but news from around the world. It just feels healthier.

0160

Dr. Don S Dizon @drdonsdizon.bsky.social · 12/03/2025

There are adverse effects from tylenol too. Nothing in medicine is 100% without adverse effects. Its about the risks and benefits, applied to populations. This cannot be taken seriously without context.

021

Reposted by Dr. Don S Dizon

Princess Vimentin PhD | Cancer Biologist @princess-vimentin.bsky.social · 08/03/2025

Regarding gutting if DEI-Comprehensive research into the biology of humans as a whole requires including investigation into the biology of women. This isn’t a “woke issue” or a DEI issue, this is a scientific issue.We can’t go back to one size fits all again. That failed us before.🧪 #academicsky

11810

Dr. Don S Dizon @drdonsdizon.bsky.social · 08/03/2025

FWIW... The law requires NIH to ensure diversity in its funded research, emphasizing inclusion of women... not females. Women. The law is on the side of diversity, equity, and Inclusion.

04610

Dr. Don S Dizon @drdonsdizon.bsky.social · 08/03/2025

A v A vestige of the AIDS epidemic, i still remember wearing this as a t-shirt when i was a resident carrying for men and women dying of HIV. It seems the lessons from that epidemic are informative today.

061

Dr. Don S Dizon @drdonsdizon.bsky.social · 07/03/2025

I will say it again. The quest for equity - and equality - are as American as apple pie. We all deserve it, and we will continue to work towards it. 6/6

010

Dr. Don S Dizon @drdonsdizon.bsky.social · 07/03/2025

That the current administration can terminate an already awarded grant, based on a prior PAR is not only unprecedented... it is soul crushing. 5/6

100

Dr. Don S Dizon @drdonsdizon.bsky.social · 07/03/2025

They underwent peer review, were scored, and were awarded. No more than 20% are awarded historically across the NIH. 4/6

100

Dr. Don S Dizon @drdonsdizon.bsky.social · 07/03/2025

For the most part, these grants responded to a program announcement. Who's announcement? It comes from the NIH. 3/6

100

Dr. Don S Dizon @drdonsdizon.bsky.social · 07/03/2025

It is because of the en blanc rejection of the granting process. 2/6

100

Reposted by Dr. Don S Dizon

SWOG Cancer Research Network @swog.org · 05/03/2025

The Winn Career Development Award is open for applications! The 2-year program provides training and support for early-stage investigator physicians to improve participation in clinical trials. Details at winnawards.org. Apply by May 12, 2025. #WinnAwards #WinnCDA @drdonsdizon.bsky.social

Winn Excellence in Clinical Trials Program

042

Reposted by Dr. Don S Dizon

Ginny Mason @ibcresearch1.bsky.social · 02/03/2025

Guess this is what happens when those in charge 'don't believe' in vaccines. Utter nonsense. Agree....it's time for others to step in and do what needs to be done. Thanks.

001

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/03/2025

Leaving Bangladesh after a 4d visit, but nourished by something that always feeds my soul, especially important now-- perspective.

030

Dr. Don S Dizon @drdonsdizon.bsky.social · 02/03/2025

How does that saying go? It's not over till it's over? I have to be an optimistic realist, but that's why academia needs to collaborate with industry. We can't do it alone. Indeed, there's a major role for our medical societies to stand up.

000

Dr. Don S Dizon @drdonsdizon.bsky.social · 01/03/2025

Perhaps its time academia and industry partner and fill this gap.

241

Dr. Don S Dizon @drdonsdizon.bsky.social · 01/03/2025

Trying to access on March 2, here in Dhaka. Definitely down.

010